SUNRISE-PD is a Phase 2b, multicenter, randomized, double-blind, placebo-controlled trial with a hybrid decentralized design that will last 20 weeks from the initial screening phase to the safety ...

Statins lower artery-clogging cholesterol and cut risks of cardiovascular disease, heart attacks and strokes. But are the drugs helpful if you have fatty liver disease, or can they be harmful? We ...

Discover how sugar quietly damages your liver through dangerous mechanisms. Learn about fatty liver disease, inflammation, ...

More than 90% of patients achieved clinically meaningful weight reduction compared to placebo in a phase 3 trial of ecnoglutide.

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit ...

Ozempic injections have a direct impact on hormonal and metabolic health — and those changes inevitably influence your ...

Skipping meals might seem like a harmless habit or even a shortcut to weight loss, but the damage it can do to your liver is ...

Insulin resistance (IR) is a crucial factor in metabolic disorders like non-alcoholic fatty liver disease (NAFLD) and polycystic ovary syndrome (PCOS), ...

Scientists at Tohoku University Graduate School of Medicine have identified colonic inflammation as a previously unrecognised ...

Infection by certain wrigglers may reduce inflammation and fight obesity and diabetes. Scientists are working to turn the ...

New research identifies the liver protein PTPRD as a key regulator of metabolic liver disease. Reduced levels of PTPRD disrupt glucose and lipid metabolism, ... and impair insulin signaling.

Excessive consumption of ultraprocessed, calorie-rich snacks even for a short period may result in fat accumulation in the liver and a temporary impairment of insulin function in the brain.